Ovarian Cancer Trial, Recruiting (NCT06085404)

Ovarian Cancer Trial, Recruiting NCT06085404 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06085404 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Doctors suspect, based on physical exams, blood tests, and scans taken before surgery, that you have a relatively advanced stage of ovarian, fallopian tube, or peritoneal cancer (stage IIIC or higher)
A quick tissue test done during surgery (called a frozen section) confirms a type of cancer that starts in the lining of the ovaries or nearby organs
You are over 18 years old
Your doctors expect you to live for at least 4 weeks
You are generally able to carry out basic daily activities with little to no limitation (confirm with trial site)

Who may not be able to join:

The tissue test done during surgery shows a type of cancer other than the "serous" type (confirm with trial site)
You have a condition that weakens your immune system, or you have been taking steroid medications (such as prednisone at a dose above 10 mg per day) or any other medication that suppresses your immune system within the 7 days before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Camilla Nero, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630158667

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06085404

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +390630158667

More information: https://clinicaltrials.gov/study/NCT06085404

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Doctors suspect, based on physical exams, blood tests, and scans taken before surgery, that you have a relatively advanced stage of ovarian, fallopian tube, or peritoneal cancer (stage IIIC or higher)
A quick tissue test done during surgery (called a frozen section) confirms a type of cancer that starts in the lining of the ovaries or nearby organs
You are over 18 years old
Your doctors expect you to live for at least 4 weeks
You are generally able to carry out basic daily activities with little to no limitation (confirm with trial site)

Who may not be able to join:

The tissue test done during surgery shows a type of cancer other than the "serous" type (confirm with trial site)
You have a condition that weakens your immune system, or you have been taking steroid medications (such as prednisone at a dose above 10 mg per day) or any other medication that suppresses your immune system within the 7 days before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

25 November 2021

Est. completion

30 April 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To improve the knowledge of advanced ovarian cancer by developing an experimental laboratory model.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov